Health A Vaccine Made for One Patient: What a New Cancer Trial Really ShowsBy Aisling CarrollOctober 16, 20260 A personalised vaccine built from a patient’s own tumour mutations was safely combined with nivolumab in an early ovarian cancer trial. Here is what that does and does not prove.
